You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 20, November 28, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Diabetes Mellitus
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Diabetes and Mortality Risk After Acute Coronary Syndromes

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their study of diabetes and mortality following acute coronary syndromes (ACS), Dr Donahoe and colleagues1 reported higher mortality in patients at 30 days and 1 year after ACS by performing subgroup analysis on pooled data from 11 independent Thrombolysis in Myocardial Infarction (TIMI) trials. The authors state that mortality remains high despite available modern evidence-based treatment. However, the data presented show that proven and available measures for secondary prevention remain underused. Adverse clinical outcomes and underuse of secondary prevention strategies have been reported to be associated with worse clinical outcomes in patients with diabetes presenting with ACS.2-3

In the study by Donahoe et al, hypolipidemic therapy was used at hospital discharge in 63.5% of patients with diabetes compared with 63.7% of patients without diabetes (P = .84). The CURE study4 showed that dual antiplatelet therapy with 3 to 12 months of thienopyridines such as clopidogrel added . . . [Full Text of this Article]

Manivannan Srinivasan, MBBS, MRCP
srinivasan.manivannan@mayo.edu

Sumit Bhagra, MBBS
Mayo Clinic
Rochester, Minnesota


RELATED LETTERS

Diabetes and Mortality Risk After Acute Coronary Syndromes
Kapil Parakh
JAMA. 2007;298(20):2367-2368.
EXTRACT | FULL TEXT  

Diabetes and Mortality Risk After Acute Coronary Syndromes—Reply
Sean M. Donahoe, Garrick C. Stewart, and Elliott M. Antman
JAMA. 2007;298(20):2368.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Diabetes and Mortality Following Acute Coronary Syndromes
Sean M. Donahoe, Garrick C. Stewart, Carolyn H. McCabe, Satishkumar Mohanavelu, Sabina A. Murphy, Christopher P. Cannon, and Elliott M. Antman
JAMA. 2007;298(7):765-775.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.